On August 26, 2021 Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, reported that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the following upcoming investor conferences (Press release, Castle Biosciences, AUG 26, 2021, View Source [SID1234586939]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Virtual Wells Fargo Healthcare Conference on Sept. 9, 2021, at 9:20 a.m. Eastern time.
Baird 2021 Global Healthcare Conference on Sept. 15, 2021, at 9:40 a.m. Eastern time.
Live audio webcasts of the company’s presentations will be available by visiting Castle Biosciences’ website at View Source Replays of the webcasts will be available for two weeks following the conclusion of the live broadcasts.

Castle will also be available on Sept. 14, 2021, for one-on-one investor meetings during the Lake Street Capital Markets 5th Annual Best Ideas Growth (BIG5) Conference. Meetings may be requested exclusively through Lake Street Capital Markets.